- Home
- SOPH vs AMRN Comparison
SOPH vs AMRN Comparison
Compare SOPH & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- AMRN
- Stock Information
- Founded
- SOPH 2011
- AMRN 1989
- Country
- SOPH Switzerland
- AMRN Ireland
- Employees
- SOPH N/A
- AMRN N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- AMRN Health Care
- Exchange
- SOPH Nasdaq
- AMRN Nasdaq
- Market Cap
- SOPH 247.0M
- AMRN 234.4M
- IPO Year
- SOPH 2021
- AMRN 1993
- Fundamental
- Price
- SOPH $3.14
- AMRN $0.61
- Analyst Decision
- SOPH Strong Buy
- AMRN Hold
- Analyst Count
- SOPH 3
- AMRN 3
- Target Price
- SOPH $7.00
- AMRN $1.00
- AVG Volume (30 Days)
- SOPH 37.0K
- AMRN 685.0K
- Earning Date
- SOPH 11-05-2024
- AMRN 10-30-2024
- Dividend Yield
- SOPH N/A
- AMRN N/A
- EPS Growth
- SOPH N/A
- AMRN N/A
- EPS
- SOPH N/A
- AMRN N/A
- Revenue
- SOPH $64,938,000.00
- AMRN $264,779,000.00
- Revenue This Year
- SOPH $7.70
- AMRN N/A
- Revenue Next Year
- SOPH $20.61
- AMRN N/A
- P/E Ratio
- SOPH N/A
- AMRN N/A
- Revenue Growth
- SOPH 20.14
- AMRN N/A
- 52 Week Low
- SOPH $2.49
- AMRN $0.56
- 52 Week High
- SOPH $7.37
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- SOPH 33.65
- AMRN 49.61
- Support Level
- SOPH $3.21
- AMRN $0.56
- Resistance Level
- SOPH $4.10
- AMRN $0.59
- Average True Range (ATR)
- SOPH 0.29
- AMRN 0.03
- MACD
- SOPH -0.08
- AMRN 0.00
- Stochastic Oscillator
- SOPH 8.15
- AMRN 50.89
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.